Correlation of serum ferritin, LDH, CRP with chest findings- CT severity index in COVID-19 patients
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20233102Keywords:
COVID-19, CRP, CTSI, Ferritin, Inflammatory markers, LDHAbstract
Background: The COVID-19 pandemic is caused by a highly infectious virus primarily transmitted from person to person. The initial clinical manifestations of the condition are non-specific, characterized by the presence of fever and cough. These symptoms may resolve independently or escalate to acute respiratory distress syndrome (ARDS), multiple organ failure, and ultimately, mortality.
Methods: The research was conducted at Moolchand Khairatiram Hospital in the COVID-19 wards and ICU in New Delhi. The blood samples were collected and then analyzed to evaluate the following parameters: C-reactive protein (CRP), serum ferritin, and LDH are the three biomarkers of interest. The statistical significance threshold was established at a p value of less than 0.05.
Results: The study included 200 patients, 49% of whom were male and 51% of whom were female. A link was discovered between the outcome and the CT severity index. Patients who had a CT severity index of 21-25 died at the highest rate. The CT severity index and ferritin were found to have a significant relationship, with patients with elevated ferritin levels reporting the highest CT severity index scores.
Conclusions: A statistically significant association was observed between the CT severity index and the outcome, with the highest mortality rate observed in patients who had a CT severity index of 21-25. The parameters above are crucial in assessing the condition and predicting the outcome of individuals afflicted with COVID-19.
References
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265-9.
Gu J, Han B, Wang J. COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020;158(6):1518-9.
WHO. (2020a) Coronavirus disease 2019 (COVID-19) situation report-41. World Health Organization. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200301-sitrep-41-covid-19.pdf?sfvrsn=6768306d_2. Accessed on 2 May 2020.
WHO. (2020b). Q and A on coronaviruses (COVID-19). World Health Organization. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19. Accessed on 2 May 2020.
Kooraki S, Hosseiny M, Myers L, Gholamrezanezhad A. Coronavirus (COVID-19) outbreak: what the department of radiology should know. J Am Coll Radiol. 2020;17(4):447-51.
WHO. (2020c) Advice on the use of masks in the context of COVID-19. World Health Organization. Available at: https://www.who.int/publications-detail/advice-on-the-use-of-masks-in-the-community-during-home-care-and-in-healthcare-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak. Accessed on 5 June 2021.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
WHO. (2020). Naming the coronavirus disease (COVID-19- 19) and the virus that causes it. World Health Organization. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/. Accessed on 5 June 2021.
Belfin RV, Brodka P, Radhakrishnan B, Rejula V. COVID-19 peak estimation and effect of nationwide lockdown in India. MedRxiv. 2020.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.
Terpos E, Ntanasis‐Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID‐19. Am J Hematol. 2020;95(7):834-47.
Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020;214:108393.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-4.
Alunno A, Carubbi F, Rodriguez-Carrio J. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a diferent origin. RMD Open. 2020;6(1):e001295.
Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese Med J. 2020;133(09):1025-31.
Wynants L, Calster BV, Bonten MMJ, Collins GS, Debray TPA, Vos MD, et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020;369.
Kooraki S, Hosseiny M, Myers L, Gholamrezanezhad A. Coronavirus (COVID-19) outbreak: what the department of radiology should know. J Am Coll Radiol. 2020;17(4):447-51.
Rod JE, Oviedo-Trespalacios O, Cortes-Ramirez J. A brief-review of the risk factors for covid-19 severity. Rev Saude Pub. 2020;54:60.
Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese Med J. 2020;133(09):1025-31.
Koo HJ, Lim S, Choe J, Choi SH, Sung H, Do KH. Radiographic and CT features of viral pneumonia. Radiographies. 2018;38(3):719-39.
Mansour MG, Abdelrahman AS, Abdeldayem EH. Correlation between CT chest severity score (CT-SS) and ABO blood group system in Egyptian patients with COVID-19. Egypt J Radiol Nucl Med. 2021;52(1):1-6.
Carubbi F, Salvati L, Alunno A, Maggi F, Borghi E, Mariani R, et al. Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 unG FDR Gits. Sci Rep. 2021;11(1):1-1.
Beydoğan E, Yürük Atasoy P. The relationship between CRP at admission and thorax CT findings in patients diagnosed with COVID-19. Int J Clin Pract. 2021;75(12):e14962.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. Erratum in: Lancet 2020;395(10223):496.
Rod JE, Oviedo-Trespalacios O, Cortes-Ramirez J. A brief-review of the risk factors for covid-19 severity. Rev Saude Pub. 2020;54:60
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62
Kooraki S, Hosseiny M, Myers L, Gholamrezanezhad A. Coronavirus (COVID-19) outbreak: what the department of radiology should know. J Am Coll Radiol. 2020;17(4):447-51.
